in Neonatal and Adult Respiratory Distress Syndrome
First Statement of Responsibility
edited by Burkhard Lachmann.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Berlin, Heidelberg
Name of Publisher, Distributor, etc.
Springer Berlin Heidelberg
Date of Publication, Distribution, etc.
1988
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(xxii, 378 pages 130 illustrations)
CONTENTS NOTE
Text of Note
Experimental Evaluation of Surfactant for Replacement Therapy --; Diagnostics of Surfactant Deficiency --; Surfactant Replacement in Newborn Infants --; Surfactant Replacement in ARDS and Other Lung Diseases --; What Happens After Surfactant Replacement Therapy?- Prospects for the Future --; Lipid Metabolism and Its Influence by Pharmacological Means.
SUMMARY OR ABSTRACT
Text of Note
This book presents state-of-the-art information from the groups who have developed and used different types of surfactant. The latest advances concerning in vivo and in vitro evaluation of different types of surfactant as well as clinical consequences, such as changes in ventilator settings following surfactant replacement therapy and immunological questions, are discussed. Apart from neonatal RDS, the book also focuses on current experimental and clinical aspects of adult RDS that offer hopeful therapeutic measures for treating this disease. Finally, new results from experimental studies on the "second generation of surfactant preparations", for example, recombinant surfactant (a combination of artificial lipids and surfactant specific human proteins produced with bioengineering methods) are presented. This book will be of value to all physicians and research workers interested in acute respiratory failure in neonates, children and adults.
PARALLEL TITLE PROPER
Parallel Title
Proceedings of the International Symposium on Surfactant Replacement Therapy, Rotterdam/The Netherlands, Nov. 14-15, 1987